Category
Fluvoxamine
CAS Number
1217214-94-2
Molecular Formula
C₁₅H₂₂F₂N₂O₂
Molecular Weight
300.34 g/mol
Synonym

2-[[[(1E)-1-[4-(Difluoromethyl)phenyl]-5-methoxypentylidene]amino]oxy]ethanamine; 2-[(E)-[1-[4-(difluoromethyl)phenyl]-5-methoxypentylidene]amino]oxyethanamine; Desfluoro fluvoxamine; (E)-1-[4-(Difluoromethyl)phenyl]-5-methoxypentan-1-one O-(2-aminoethyl) oxime; 1-[4-(Difluoromethyl)phenyl]-5-methoxy-1-pentanone O-(2-aminoethyl)oxime;1-Pentanone, 1-[4-(difluoromethyl)phenyl]-5-methoxy-, O-(2-aminoethyl)oxime

Keywords
Metabolites.
Impurities
Intermediates
Pharmaceutical Standards
Fine Chemicals
slide_1
Purity:

Above - 95.0%

Technical Data:

We will provide complete documentation support for every Standard Material. All analytical reports such as ¹H NMR, ¹³C NMR, Mass, FT-IR, HPLC Purity/GC Purity/QNMR Purity, Water content by KF/ Loss on Drying/TGA (Thermo-gravimetric Analysis). Certificate of Analysis with potency report. Each Standard Material SER (Structure Elucidation Report) with NMR, Mass, IR spectral interpretation. This whole analytical document can be included in eCTD, ANDA, DMF submissions to regulatory agencies.

Fluvoxamine EP Impurity E is a specified impurity associated with fluvoxamine and may originate from the manufacturing process or from degradation of the active pharmaceutical ingredient. It is evaluated during analytical testing to assess the chemical purity and stability of fluvoxamine. Control of this impurity is important for maintaining consistent pharmaceutical quality and compliance with applicable pharmacopoeial requirements.